Cost-utility analyses of clinical preventive services
Authors:
- Patricia W. StonePSPatricia W. Stone
- Steven TeutschSTSteven Teutsch
- Richard H. ChapmanRCRichard H. Chapman
- Chaim BellCBChaim Bell
- Sue J. GoldieSGSue J. Goldie
- Peter J. NeumannPNPeter J. Neumann
Open Access
- 1 July 2000
- journal article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 19 (1) , 15-23
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- PPR7: A FORMAL AUDIT OF 228 PUBLISHED COST-UTILITY ANALYSESValue in Health, 1999
- Cost-Effectiveness of Screening for Asymptomatic Carotid Atherosclerotic DiseaseStroke, 1996
- Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor StudyTransfusion, 1995
- In search of the best upper age limit for breast cancer screeningEuropean Journal of Cancer, 1995
- Cost-per-QALY League TablesPharmacoEconomics, 1994
- Cost-effectiveness of preoperative autologons donation in coronary artery bypass graftingThe Annals of Thoracic Surgery, 1994
- Cost-effectiveness league tables: More harm than good?Social Science & Medicine, 1993
- Cost-utility in practice: A policy maker's guide to the state of the artHealth Policy, 1992
- Cost Effectiveness of Vaccination against Pneumococcal PneumoniaNew England Journal of Medicine, 1980
- Estrogen Use in Postmenopausal Women — Costs, Risks, and BenefitsNew England Journal of Medicine, 1980